Group 1 - The latest stock price of Yifang Biotech-U is 42.18 yuan, up 0.55% from the previous trading day, with an intraday high of 43.79 yuan and a low of 41.75 yuan, and a trading volume of 554 million yuan [1] - The company operates in the biopharmaceutical industry, focusing on innovative drug development, with 2 products already on the market, 1 in the registration clinical trial phase, 2 in Phase II clinical trials, and several preclinical projects [1] - The company reported a revenue of 19.16 million yuan for the first half of 2025, representing a year-on-year growth of 28.85% [1] Group 2 - The company has applied for 37 new invention patents recently, with a total of 138 invention patents authorized domestically and internationally [1] - The company announced plans to use no more than 1 billion yuan of idle raised funds for cash management, aimed at purchasing safe and liquid financial products [1] - On August 25, the net inflow of main funds was 46.54 million yuan, with a cumulative net inflow of 112.73 million yuan over the past five days [1]
益方生物-U股价微涨0.55% 上半年营收同比增长28.85%